Remimazolam not checked

Acacia Pharma Ltd

FollowEvery change as it happens, and a Monday email
Stage
in the US
Next date
Phase 2/3 trial completes
Trials
6 active
8 in total · 7 in the EU

What this is

How it works
How it works isn't classified yet
Tested for
Pediatric ALL
Main trialPhase 2/3
“To assess the efficacy of intravenous remimazolam in inducing and maintaining suitable sedation levels for paediatric patients undergoing diagnostic and/or therapeutic procedures”In the company’s words, NCT04851717 on ClinicalTrials.gov

Other drugs for Pediatric ALL

All 59 drugs for Pediatric ALL

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials8

TrialPhaseCompletesWhat it tests
Phase 2/3Active, not recruiting Oct 2027 Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures
Phase 4Ended not given Efficacy of Remimazolam with Fentanyl versus Midazolam with Fentanyl for sedation in screening colonoscopy: A randomized controlled study
Phase 4Authorised not given Rapid sequence emergence of general Anaesthesia
Phase 4Authorised not given Remimazolam versus Midazolam for sedation during upper GI endoscopy: a randomized controlled trial
Phase 2Ended not given The sedative effects and local tolerability of nasal administration of remimazolam using a Soft Mist Nasal Administration Device
Phase 2Authorised not given Efficacy and safety of Remimazolam compared to Ketamine and Propofol in Rapid Sequence Induction. A monocentric pilot randomised-controlled study
Phase 4Authorised not given Remimazolam versus propofol for deep sedation during Endoscopic Ultrasound (EUS) procedures. A randomized controlled trial.
Phase 4Authorised not given Efficacy, Safety, and Patient Satisfaction of Patient-Controlled Remimazolam Sedation in Outpatient Colonoscopy: A randomized controlled trial.
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Remimazolam

Following is part of Solo: you see every change to Remimazolam the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in